リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Effects of Traditional Kampo Drugs and Their Constituent Crude Drugs on Influenza Virus Replication In Vitro: Suppression of Viral Protein Synthesis by Glycyrrhizae Radix」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Effects of Traditional Kampo Drugs and Their Constituent Crude Drugs on Influenza Virus Replication In Vitro: Suppression of Viral Protein Synthesis by Glycyrrhizae Radix

野村 俊仁 広島大学

2020.03.23

概要

Influenza viruses, which belong to the family Orthomyxoviridae, are enveloped viruses with segmented, singlestranded, negative-sense RNA genomes [1]. In seasonal
influenza epidemics, mortality is a particular concern in the
elderly [2], and some children may require inpatient care [3].
In addition, a new type of influenza virus may emerge and
cause a pandemic. Several antiviral drugs including neuraminidase inhibitors have been developed for treatment of
influenza. However, there are problems such as high cost
and the possibility of appearance of drug-resistant virus
variants. The development of new anti-influenza drugs and
the establishment of novel therapeutic measures are needed. ...

この論文で使われている画像

参考文献

[1] M. L. Shaw and P. Palese, “Orthomyxoviridae,” in Fields

Virology, D. M. Knipe and P. M. Howley, Eds., vol. 1,

pp. 1151–1185, Lippincott Williams & Wilkins, Philadelphia,

PA, USA, 2013.

[2] W. W. Thompson, “Mortality associated with influenza and

respiratory syncytial virus in the United States,” Jama,

vol. 289, no. 2, pp. 179–186, 2003.

12

[3] K. A. Poehling, K. M. Edwards, G. A. Weinberg et al., “The

underrecognized burden of influenza in young children,” New

England Journal of Medicine, vol. 355, no. 1, pp. 31–40, 2006.

[4] Tumura & Co., About Kampo, 2016, https://www.tsumura.co.

jp/english/kampo/.

[5] T. Kubo and H. Nishimura, “Antipyretic effect of Mao-to, a

Japanese herbal medicine, for treatment of type A influenza

infection in children,” Phytomedicine, vol. 14, no. 2-3,

pp. 96–101, 2007.

[6] Y. Toriumi, T. Kamei, K. Murata, I. Takahashi, N. Suzuki, and

O. Mazda, “Utility of maoto in an influenza season where

reduced effectiveness of oseltamivir was observed—a clinical,

non-randomized study in children,” Forschende Komplement¨armedizin/Research in Complementary Medicine, vol. 19,

no. 4, pp. 179–186, 2012.

[7] T. Miyazaki, “Chinese herbal medicines to inhibit the replication of influenza viruses,” Folia Pharmacologica Japonica,

vol. 140, no. 2, pp. 62–65, 2012.

[8] K. Noma, K. Kiyotani, H. Kouchi et al., “Endogenous protease-dependent replication of human influenza viruses in

two MDCK cell lines,” Archives of Virology, vol. 143, no. 10,

pp. 1893–1909, 1998.

[9] T. Kawahara, I. Akiba, M. Sakou, T. Sakaguchi, and

H. Taniguchi, “Inactivation of human and avian influenza

viruses by potassium oleate of natural soap component

through exothermic interaction,” PLoS One, vol. 13, no. 9,

Article ID e0204908, 9 pages, 2018.

[10] K. Ueda, R. Kawabata, T. Irie, Y. Nakai, Y. Tohya, and

T. Sakaguchi, “Inactivation of pathogenic viruses by plantderived tannins: strong effects of extracts from persimmon

(Diospyros kaki) on a broad range of viruses,” PLoS One,

vol. 8, no. 1, Article ID e55343, 10 pages, 2013.

[11] T. Sakaguchi, K. Kiyotani, A. Kato et al., “Phosphorylation of

the Sendai virus M protein is not essential for virus replication

either in vitro or in vivo,” Virology, vol. 235, no. 2, pp. 360–366,

1997.

[12] N. Mantani, T. Andoh, H. Kawamata, K. Terasawa, and

H. Ochiai, “Inhibitory effect of Ephedrae herba, an oriental

traditional medicine, on the growth of influenza A/PR/8 virus

in MDCK cells,” Antiviral Research, vol. 44, no. 3, pp. 193–

200, 1999.

[13] T. Nagai, E. Kataoka, Y. Aoki, R. Hokari, H. Kiyohara, and

H. Yamada, “Alleviative effects of a kampo (a Japanese herbal)

medicine “maoto (Ma-Huang-Tang)” on the early phase of

influenza virus infection and its possible mode of action,”

Evidence-Based Complementary and Alternative Medicine,

vol. 2014, Article ID 187036, 12 pages, 2014.

[14] J. L. McKimm-Breschkin, “Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance,” Influenza and Other Respiratory Viruses, vol. 7, no. 1, pp. 25–36,

2013.

[15] R. O’Hanlon and M. L. Shaw, “Baloxavir marboxil: the new

influenza drug on the market,” Current Opinion in Virology,

vol. 35, pp. 14–18, 2019.

[16] Y. Ishijima, T. Kawamura, A. Kimura et al., “Toll-like receptor

4-dependent adjuvant activity of Kakkon-to extract exists in

the high molecular weight polysaccharide fraction,” International Journal of Immunopathology and Pharmacology,

vol. 24, no. 1, pp. 43–54, 2011.

[17] K. Ohara, S. Oshima, N. Fukuda et al., “The inhibitory effect of

kakkonto, Japanese traditional (kampo) medicine, on brain

penetration of oseltamivir carboxylate in mice with reduced

blood-brain barrier function,” Evidence-Based Complementary

Evidence-Based Complementary and Alternative Medicine

[18]

[19]

[20]

[21]

[22]

and Alternative Medicine, vol. 2015, Article ID 917670, 11 pages,

2015.

K. Hayashi, N. Imanishi, Y. Kashiwayama et al., “Inhibitory

effect of cinnamaldehyde, derived from Cinnamomi cortex,

on the growth of influenza A/PR/8 virus in vitro and in vivo,”

Antiviral Research, vol. 74, no. 1, pp. 1–8, 2007.

S. Ji, Z. Li, W. Song et al., “Bioactive constituents of Glycyrrhiza uralensis (licorice): discovery of the effective components of a traditional herbal medicine,” Journal of Natural

Products, vol. 79, no. 2, pp. 281–292, 2016.

M. Ramalingam, H. Kim, Y. Lee, and Y.-I. Lee, “Phytochemical and pharmacological role of liquiritigenin and

Isoliquiritigenin from Radix Glycyrrhizae in human health

and disease models,” Frontiers in Aging Neuroscience, vol. 10,

Article ID 348, 15 pages, 2018.

M. Kobayashi, S. M. Davis, T. Utsunomiya, R. B. Pollard, and

F. Suzuki, “Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in

mice,” The American Journal of Chinese Medicine, vol. 27,

no. 1, pp. 53–62, 1999.

R. Shirayama, M. Shoji, N. Sriwilaijaroen, H. Hiramatsu,

Y. Suzuki, and T. Kuzuhara, “Inhibition of PA endonuclease

activity of influenza virus RNA polymerase by Kampo

medicines,” Drug Discoveries & Therapeutics, vol. 10, no. 2,

pp. 109–113, 2016.

MEDIATORS

of

INFLAMMATION

The Scientific

World Journal

Hindawi Publishing Corporation

http://www.hindawi.com

www.hindawi.com

Volume 2018

2013

Gastroenterology

Research and Practice

Hindawi

www.hindawi.com

Volume 2018

Journal of

Hindawi

www.hindawi.com

Diabetes Research

Volume 2018

Hindawi

www.hindawi.com

Volume 2018

Hindawi

www.hindawi.com

Volume 2018

International Journal of

Journal of

Endocrinology

Immunology Research

Hindawi

www.hindawi.com

Disease Markers

Hindawi

www.hindawi.com

Volume 2018

Volume 2018

Submit your manuscripts at

www.hindawi.com

BioMed

Research International

PPAR Research

Hindawi

www.hindawi.com

Hindawi

www.hindawi.com

Volume 2018

Volume 2018

Journal of

Obesity

Journal of

Ophthalmology

Hindawi

www.hindawi.com

Volume 2018

Evidence-Based

Complementary and

Alternative Medicine

Stem Cells

International

Hindawi

www.hindawi.com

Volume 2018

Hindawi

www.hindawi.com

Volume 2018

Journal of

Oncology

Hindawi

www.hindawi.com

Volume 2018

Hindawi

www.hindawi.com

Volume 2013

Parkinson’s

Disease

Computational and

Mathematical Methods

in Medicine

Hindawi

www.hindawi.com

Volume 2018

AIDS

Behavioural

Neurology

Hindawi

www.hindawi.com

Research and Treatment

Volume 2018

Hindawi

www.hindawi.com

Volume 2018

Hindawi

www.hindawi.com

Volume 2018

Oxidative Medicine and

Cellular Longevity

Hindawi

www.hindawi.com

Volume 2018

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る